Lv1
40 积分 2025-02-12 加入
The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
2个月前
已完结
Antibody-drug conjugates specifically regulate tumor microenvironment: A promising strategy for pancreatic cancer treatment
2个月前
已完结
Reprogramming the tumor immune microenvironment via Antibody-drug conjugates
2个月前
已完结
Antibody-drug conjugates specifically regulate tumor microenvironment: A promising strategy for pancreatic cancer treatment
2个月前
已完结
Molecular alterations of muc1 and their therapeutic exploitation: Emerging opportunities in cancer therapy
2个月前
已关闭
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
2个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
2个月前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors
4个月前
已完结
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain
5个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
6个月前
已完结
皖公网安备34019202002308
